Insider Transactions in Q4 2025 at Apellis Pharmaceuticals, Inc. (APLS)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 21
2025
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.27%
|
$280,000
$28.03 P/Share
|
|
Oct 21
2025
|
Timothy Eugene Sullivan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.64%
|
$100,000
$10.03 P/Share
|
|
Oct 16
2025
|
David O. Watson General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-4.21%
|
$125,000
$25.22 P/Share
|
|
Oct 10
2025
|
A. Sinclair Dunlop |
SELL
Other acquisition or disposition
|
Indirect |
3,837
-100.0%
|
-
|
|
Oct 10
2025
|
A. Sinclair Dunlop |
SELL
Open market or private sale
|
Indirect |
31,092
-89.01%
|
$715,116
$23.72 P/Share
|